Venus Concept Inc. (NASDAQ:VERO – Get Free Report) saw a significant decrease in short interest during the month of October. As of October 15th, there was short interest totalling 70,500 shares, a decrease of 91.3% from the September 30th total of 812,700 shares. Based on an average daily volume of 1,170,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 1.7% of the shares of the company are short sold.
Insider Buying and Selling at Venus Concept
In other Venus Concept news, major shareholder Michael Willingham Masters sold 94,553 shares of the company’s stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $0.53, for a total value of $50,113.09. Following the sale, the insider now directly owns 17,059 shares of the company’s stock, valued at approximately $9,041.27. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 51.39% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Venus Concept stock. Masters Capital Management LLC grew its position in Venus Concept Inc. (NASDAQ:VERO – Free Report) by 100.0% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 666,702 shares of the company’s stock after acquiring an additional 333,366 shares during the period. Masters Capital Management LLC owned about 10.49% of Venus Concept worth $522,000 at the end of the most recent quarter. 87.41% of the stock is currently owned by hedge funds and other institutional investors.
Venus Concept Price Performance
Venus Concept (NASDAQ:VERO – Get Free Report) last issued its quarterly earnings data on Tuesday, August 13th. The company reported ($1.39) earnings per share for the quarter. The business had revenue of $16.58 million for the quarter. Equities analysts expect that Venus Concept will post -6.37 earnings per share for the current fiscal year.
Venus Concept Company Profile
Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
See Also
- Five stocks we like better than Venus Concept
- Investing in Commodities: What Are They? How to Invest in Them
- Texas Roadhouse Stock Steering for New Highs This Year
- Consumer Staples Stocks, Explained
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Investing in the High PE Growth Stocks
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.